Two closely related human members of chitinase-like family, CHI3L1 and CHI3L2, activate ERK1/2 in 293 and U373 cells but have the different in-fluence on cell proliferation

International Journal of Biological Sciences

Volumn 8, Issue 1, 2011, Pages 39-48

  Areshkov, Pavlo O ^a   Avdieiev, Stanislav S ^a   Balynska, Olena V ^a   LeRoith, Derek ^b   Kavsan, Vadym M ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Chitinase 3 like 1 (CHI3L1, HC gp 39, YKL 40) protein; Chitinase 3 like 2 (CHI3L2, YKL 39) protein; ERK1 2; MAP kinase

Indexed keywords

EID: 81255128811     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.8.39     Document Type: Article

References (26)

1. Raman M, Chen W, Cobb MH. Differential regulation and properties of MAPKs. Oncogene 2007; 26: 3100-12.
2. Traverse S, Gomez N, Paterson H, et al. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J. 1992; 288: 351-55.
3. Murphy LO, Smith S, Chen RH, et al. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol. 2002; 4: 556-64.
4. Henrissat B, Davies G. Structural and sequence-based classifi-cation of glycoside hydrolases. Curr Opin Struct Biol. 1997; 7: 637-44.
5. Bussink AP, Speijer D, Aerts JM, et al. Evolution of mammalian chitinase(-like) members of family 18 glycosyl hydrolases. Ge-netics. 2007; 177: 959-70.
6. Fusetti F, Pijning T, Kalk KH, et al. Crystal structure and car-bohydrate-binding properties of the human cartilage glyco-protein-39. J Biol Chem. 2003; 278: 37753-60.
7. Garifulin OM, Shostak KO, Dmitrenko VV, et al. Increased expression of SOX-2 and HC gp-39 genes in astrocytic tumours. Biopol and Cell. 2002; 18: 324-29.
8. Tanwar MK, Gilbert MR, Holland EC. Gene expression micro-array analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma. Cancer Res. 2003; 62: 4364-68.
9. Shostak KO, Labunskyy VN, Dmitrenko VV, et al. HC gp-39 gene is upregulated in glioblastomas. Cancer Lett. 2003; 198: 203-10.
10. Saidi A, Javerzat S, Bellahcène A, et al. Experimental an-ti-angiogenesis causes upregulation of genes associated with poor survival in glioblastoma. Int J Cancer. 2008; 122: 2187-98.
11. Lee CG, Hartl D, Lee GR, et al. Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis. J Exp Med. 2009; 206: 1149-66.
12. Kavsan VM, Baklaushev NP, Balynska OV, et al. Gene encoding chitinase 3-like 1 protein (CHI3L1) is a putative oncogene. Intern J Biomed Sci. In press.
13. Recklies AD, White C, Ling H. The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates prolif-eration of human connective-tissue cells and activates both ex-tracellular signal-regulated kinase-and protein kinase B-mediated signalling pathways. Biochem J. 2002; 365: 119-26.
14. Hu B, Trinh K, Figueira WF, et al. Isolation and sequence of a novel human chondrocyte protein to mammalian members of the chitinase protein family. J Biol Chem. 1996; 271: 19415-20.
15. Kavsan V, Dmitrenko V, Boyko O, et al. Overexpression of YKL-39 gene in glial brain tumors. Scholarly Research Exchange. 2008; doi: 10.3814/2008/814849.
16. Areshkov P, Kavsan V. Chitinase 3-like protein 2 (CHI3L2, YKL-39) activates phosphorylation of extracellular sig-nal-regulated kinases ERK1/ERK2 in human embryonic kidney (HEK293) and human glioblastoma (U87 MG) cells. Tsitol Genet. 2010; 44: 3-9.
17. Harvey S, Weisman M, O'Dell J, et al. Chondrex: new marker of joint disease. Clin Chem. 1998; 44: 509-16.
18. Iershov A, Odynets K, Kornelyuk A, et al. Homology modeling of 3D structure of human chitinase-like protein CHI3L2 protein. Central Eur J Bio. 2010; 5: 407-20.
19. Johansen JS. Studies on serum CHI3L1 as a biomarker in dis-eases with inflammation, tissue remodelling, fibroses and can-cer. Dan Med Bull. 2006; 53: 172-209.
20. De Ceuninck F, Gaufillier S, Bonnaud A, et al. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun. 2001; 285: 926-31.
21. Moriguchi T, Gotoh Y, Nishida E. Roles of the MAP kinase cascade in vertebrates. Adv Pharmacol. 1996; 36: 121-37.
22. Waskiewicz AJ, Cooper JA. Mitogen and stress response path-ways: MAP kinase cascades and phosphatase regulation in mammals and yeast. Curr Opin Cell Biol. 1995; 7: 798-805.
23. Datta SR, Brunet A, Greenberg ME. Cellular survival: a play in three akts. Genes Dev. 1999; 13: 2905-27.
24. Schramek H. MAP kinases: from intracellular signals to physi-ology and disease. News Physiol Sci. 2002; 17: 62-7.
25. Marshall CJ. Specificity of Receptor Tyrosine Kinase Signaling: Transient versus Sustained Extracellular Signal-Regulated Ki-nase Activation. Cell. 1995; 80: 179-85.
26. Pouysségur J, Volmat V, Lenormand P. Fidelity and spa-tio-temporal control in MAP kinase (ERKs) signalling. Biochem Pharmacol. 2002; 64: 755-63.